The Vital Prognosis of Subclavian Stenosis
Victor Aboyans, MD, PhD*, ,1,*,
Michael H. Criqui, MD, MPH*, ,
Mary McGrae McDermott, MD ,
Matthew A. Allison, MD, MPH*,
Julie O. Denenberg, MA*,
Ramin Shadman, BA and
Arnost Fronek, MD, PhD||
* Department of Family and Preventive Medicine, University of California-San Diego, La Jolla, California
Department of Thoracic and Cardiovascular Surgery and Vascular Medicine, Dupuytren University Hospital, Limoges, France
Department of Medicine, University of California-San Diego, La Jolla, California
Northwestern University Feinberg School of Medicine, Chicago, Illinois
|| Department of Surgery and Bio-Engineering, University of California-San Diego, La Jolla, California.

View larger version (11K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 7-Year Survival According to Presence of Any CVD and Presence of SS
Any cardiovascular disease (CVD) represents clinical CVD and/or an ankle-brachial index (ABI) <0.90. SS = subclavian stenosis.
|
|
|